Drugmakers Pfizer and BioNTech wanted to charge the EU Commission €54.08 per dose of their Coronavirus vaccine, according to German media reports. The jab would have cost more than 20 times that of a rival shot from AstraZeneca.
The prospective price tag was revealed on Thursday by German broadcasters NDR and WDR, and the Suddeutsche Zeitung newspaper. The paper claims that Pfizer and BioNTech submitted a bid to the EU offering 500 million doses at €54.08 ($65.58) per dose, for a total cost of €27 billion ($32.74 billion).
app that delivers the latest headlines to you.RTLIVE
Pfizer-BioNTech tried to gouge the EU with 65-DOLLAR vaccine doses, German media report
19 Feb, 2021 18:47
FILE PHOTO: Vials labelled “COVID-19 Coronavirus Vaccine” and a syringe are seen in front of the Pfizer logo in this illustration taken February 9, 2021 © Reuters / Dado Ruvic
- 51
Follow RT onDrugmakers Pfizer and BioNTech wanted to charge the EU Commission €54.08 per dose of their Coronavirus vaccine, according to German media reports. The jab would have cost more than 20 times that of a rival shot from AstraZeneca.
The prospective price tag was revealed on Thursday by German broadcasters NDR and WDR, and the Suddeutsche Zeitung newspaper. The paper claims that Pfizer and BioNTech submitted a bid to the EU offering 500 million doses at €54.08 ($65.58) per dose, for a total cost of €27 billion ($32.74 billion).ALSO ON RT.COMPandemic will be with us until EVERYONE on earth given Covid-19 vaccine, says Merkel after G7 summit
At €54.08, the BioNTech vaccine would have cost more than 20 times as much as the rival vaccine developed by AstraZeneca and Oxford University, and 500 million doses would have cost the EU €3 billion more than the annual GDP of Iceland. In comparison, Russia’s ‘Sputnik V’ vaccine was expected to be priced at no more than $10 (€8.26), according to its backers.
“I see it as a pursuit of profit that is in no way justified in the current situation of the pandemic,” Wolf Dieter Ludwig, drug chairman of the German Medical Association, told the newspaper.
Pfizer-BioNTech has made no profit on the sale of vaccines, according to the Suddeutsche Zeitung, and during negotiations last year reportedly told EU officials that the €54.08 price tag already included “the highest percentage discount” offered to any developed country.
The final cost per dose of the vaccine is still unknown, though a document leaked by Belgian MP Eva De Bleeker in December suggested that Pfizer-BioNTech had been bargained down to €12 ($14.55). Reuters later stated that it had reviewed documents showing the price at €15.50 ($18.79) per dose, “slightly lower than the $19.50 per shot the United States agreed to pay for a first shipment of 100 million doses of the same vaccine.”
The European Commission has thus far secured 600 million doses of the Pfizer-BioNTech vaccine, 460 million Moderna shots, and 400 million AstraZeneca doses. A further 1.1 billion doses of vaccines by other manufacturers, including Johnson & Johnson and CureVac, have been reserved, but these vaccines are still under development or evaluation.
Individual countries have set their sights further afield, however: Hungary last week became the first EU country to start administering Russia’s ‘Sputnik V’, and will soon deploy China’s Sinovac shot too. The Czech Republic is also considering buying the Russian vaccine, should it be approved by EU regulators.
Credit: RT News